20_08_OP_OPVirtual_SolutionPageHeader2


Welcome to OP-Virtual – An online interactive forum to discuss the most important topics and trends impacting drug development and manufacturing outsourcing, and working with CDMOs.

Throughout the year, our Chief Editor, Louis Garguilo, brings together industry experts to discuss how sponsor companies can tackle some of today's biggest challenges in managing your CDMOs. Our audience gets to ask and have answered their questions during the presentation. Each OP-Virtual session is archived, and can be accessed at any time by registered site users.

WHAT COVID-19 VACCINES TEACH US ABOUT ALL TECH TRANSFERS

  • What COVID-19 Vaccines Teach Us About All Tech Transfers

    Are there “lessons learned” and “best practices” from the COVID-19 vaccine efforts you can apply to tech transfers of your own projects — be they small molecule, biologics, or cell and gene therapies? View the On-Demand version of OP-Virtual from our discussion on November 4, 2020 on what we’ve learned thus far, and how to “transfer” that knowledge to your projects.

HOW TO HIRE A NEW GENERATION OF BIOPHARMA WORKERS FOR AN OUTSOURCING MODEL

  • How to Hire A New Generation Of Biopharma Workers For An Outsourcing Model

    Are you productively filling the open positions in your organization? New recruiting strategies are needed to attract and keep the best of a new generation of biopharma worker. In today’s highly outsourced model, technical experience must be matched carefully with “people skills,” and the right attitudes. Not to mention currently you have to do this in the middle of the COVID-19 pandemic. Some good news? We assembled a panel of experienced HR and external supply chain professionals, and the founder of three Centers for Biopharma Education and Training (CBET), to offer you their best practices, and answer your questions.

A NEW DECADE OF OUTSOURCING: WHAT CAN WE EXPECT?

  • A New Decade Of Outsourcing: What Can We Expect?

    Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light. Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."

MANAGING YOUR CDMOS - ADVICE FROM PROFESSIONALS WHO HAVE BEEN ON BOTH SIDES OF OUTSOURCING

PODCASTS WITH CHIEF EDITOR LOUIS GARGUILO

Louis_Photo_2019

Louis Garguilo



Louis Garguilo is chief editor and conference chair for Outsourced Pharma, and a contributing editor to Life Science Leader magazine. He studied public relations and journalism at Syracuse University (and holds a Master’s in English), and has 30+ years of international experience in business communications and development positions. Louis spent a decade at a global pharmaceutical contract research, development and manufacturing organization; served under the governor of New York in the state’s economic development agency, as liaison to the pharmaceutical/biotechnology industry; was chief strategic officer for an e-learning software company; and spent most of the ‘80s and ‘90s in Japan as an educator, author, and business communications consultant, including for the Osaka Medical Center for Cancer and Cardiovascular Diseases.